Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...

全面介紹

Na minha lista:
書目詳細資料
發表在:HIV Med
Main Authors: Soliman, Elsayed Z., Sharma, Shweta, Arastéh, Keikawus, Wohl, David, Achhra, Amit, Tambussi, Giuseppe, O’Connor, Jemma, Stein, James H., Duprez, Daniel A., Neaton, James D., Phillips, Andrew
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/
https://ncbi.nlm.nih.gov/pubmed/25711323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍